ENTPD1 and glioblastoma: Meng et al. developed a risk evaluating model based on six lncRNAs (AC005013.5, UBE2R2-AS1, ENTPD1-AS1, RP11-89C21.2, AC073115.6, and XLOC_004803) to assess the prognosis of glioblastoma patients [29].